المصدر: NASDAQ US Markets / 24 أبريل 2025 03:54:25 America/New_York
(RTTNews) - Hikma Pharmaceuticals Plc (HIK, HIK.L), on Thursday, reiterated its full-year guidance following a solid start to 2025, highlighting strong performance across its core business segments.
https://www.nasdaq.com/articles/hikma-pharma-reaffirms-fy25-guidance-amid-strong-start